Cargando…
Feasibility of Mediastinal Radiation Use in HeartMate 3 LVAD Recipients with Cancer
The HeartMate 3 left ventricular assist device possesses the unique feature of having its electronics and software located within the housing of the pump, which may predispose it to malfunction from radiation exposure during cancer treatment. We investigated this association in a case series of two...
Autores principales: | Butt, Nausharwan, Sheikh, Farooq H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Houston Methodist DeBakey Heart & Vascular Center
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881437/ https://www.ncbi.nlm.nih.gov/pubmed/36742441 http://dx.doi.org/10.14797/mdcvj.1115 |
Ejemplares similares
-
Hemocompatibility and hemodynamic comparison of two centrifugal LVADs: HVAD and HeartMate3
por: Gil, Antonio, et al.
Publicado: (2023) -
Use of Intracorporeal Durable LVAD Support in Children Using HVAD or HeartMate 3—A EUROMACS Analysis
por: Schweiger, Martin, et al.
Publicado: (2023) -
Left ventricular assist device exchange from HeartMate II to HeartMate 3 in an Asian patient—a case report and literature review
por: Chang, Hsiao-Huang, et al.
Publicado: (2023) -
HeartMate 3 Explantation Using Felt Plug for Ventriculotomy Occlusion
por: Medina, Melissa, et al.
Publicado: (2023) -
HeartMate 3 biventricular support exceeding 4.5 years
por: Gasparovic, Hrvoje, et al.
Publicado: (2023)